Antipsychotic-induced weight gain: a review of the literature.
about
Atypicality of atypical antipsychotics.Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the MythsContemporary assessment and pharmacotherapy of Tourette syndromeTen putative contributors to the obesity epidemicSide effects of atypical antipsychotics: a brief overviewWeight loss dynamics during combined fluoxetine and olanzapine treatmentChanges in body weight and psychotropic drugs: a systematic synthesis of the literatureEuropean clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentPerspectives of Overweight Latinos with Serious Mental Illness on Barriers and Facilitators to Health Behavior Change.Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.Using internet enabled mobile devices and social networking technologies to promote exercise as an intervention for young first episode psychosis patients.Circuits controlling energy balance and mood: inherently intertwined or just complicated intersections?Recent advances in Tourette syndrome.Vitamin D Levels in Different Severity Groups of Schizophrenia.Modern antipsychotic drugs: a critical overviewMetabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.Efficacy and tolerability of aripiprazole in patients with schizophrenia & schizoaffective disorders.Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.Dietary intake of patients with schizophreniaSymptom control and patient adherence to treatment: key goals in the treatment of psychosis.Weight gain, obesity, and psychotropic prescribing.Body mass index and quality of life among outpatients with schizophrenia in JapanWeight gain and new onset diabetes associated with olanzapine and risperidone.Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional studySafety and tolerability of antipsychotics: focus on amisulpride.Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate.A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness.Understanding antipsychotic "atypicality": a clinical and pharmacological moving targetAssociation of Allelic Variation in Genes Mediating Aspects of Energy Homeostasis with Weight Gain during Administration of Antipsychotic Drugs (CATIE Study).Antipsychotics inhibit glucose transport: Determination of olanzapine binding site in Staphylococcus epidermidis glucose/H(+) symporter.The neurobiology of psychopathic traits in youths.Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adultsThe Metabolic Syndrome in Patients With Severe Mental IllnessesCost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses.Effect of Psychotropic Drugs on Development of Diabetes Mellitus in Patients With Alzheimer's DiseaseLong-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia.Attitudes toward metabolic adverse events among patients with schizophrenia in Japan.Association Between Antipsychotic Treatment and Advanced Diabetes Complications Among Schizophrenia Patients With Type 2 Diabetes Mellitus.Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathwayA case series: evaluation of the metabolic safety of aripiprazole
P2860
Q24535908-CFEF74DC-F90C-4D6C-B0AB-0BFA77051621Q24596954-AF7B3556-4A8A-450C-A5F8-F898148B402EQ24607941-E84A07E9-E48B-4A33-BB61-75DCCC10A3A1Q24619245-8D2CE5E7-9C01-444C-9DEC-C559C2CF12D8Q24642721-4A8807F3-D49F-4FF6-9A00-7CD35A95C37EQ24794172-D1E0528E-527A-4588-BDFE-4B921D33F480Q28728401-79522C77-DE7C-4A8A-BEBA-7184A1086A86Q28972478-3E3D0A87-783A-4CB3-85F0-46606B1B96FCQ30371570-CE4A2842-01FF-4A88-8FF7-E42B6500D5A4Q30393802-4EADE74F-1C69-4288-9916-6A73A65E1C96Q30501289-9389C129-EE11-4479-ABCE-201791BEE436Q33717463-2B35FA8F-4A9B-48DA-AE2C-40746CE8D23EQ33786160-C1D6605F-690E-45F9-BD90-665A1A55C44DQ33790336-2B2B23B3-1518-46B7-9A1B-A520A0E26D3CQ33853390-1EC1B4BA-36EB-41AC-9351-E95D9E9DCB5AQ33935882-5756D408-38DC-4A40-9458-7CBA7F4FA874Q34174978-BF6EE7BC-E0B7-464E-9465-3C6083B90AACQ34248044-A712DC47-381E-4FEF-8A9F-1F3D9DFEBA4BQ34418604-78CA086A-B088-4F5B-9DC3-5F5398B1356CQ34450843-D22888E3-A09F-4D0D-9E12-BE44AFD64A5CQ34557537-19CFA9FD-D696-435A-B277-85F748CD5137Q34660592-B8B1D872-A6DB-451A-9F2B-6A700E54976FQ34733828-0AAF43DB-A352-4594-B535-4BAEFBF99D38Q34944648-91D0A187-AB22-404E-A515-704741E1FF29Q35026487-0C79ED9A-20DA-48B8-B68D-6458BD9B6C24Q35100107-7CA333F9-5BC0-460E-BDC2-A1FCBFFE4C9EQ35185643-1EDA5AD6-C615-4664-848D-A2E5CB8C49B2Q35200831-7D306352-A556-45F0-A09C-A413200FDFC5Q35460642-D777AB0A-8309-4222-B48A-297FA7062F5BQ35547830-B1A4ACA4-0FC1-41F2-84D7-9C1E97221F38Q35565713-7247BC4F-F575-4D3A-96E2-5E78B2CA659EQ35791125-F28D691E-77B1-4F79-8CAA-3BD09EC1A29BQ35884715-C4987B1B-3762-4600-AA41-65AB05531913Q36110777-0193A363-4E79-452A-BF38-427D9DD4FAC7Q36194233-621D10BC-F1C0-4C3A-A0BD-5DE916332F12Q36202865-23FB7FB0-53CA-43BB-8343-C3DACD593496Q36631551-36C49B65-1595-4E67-B684-28F9E31116BFQ36817257-8CA7C6F5-EDC6-466E-8510-BEA1F23128CAQ36835108-EE52FAA8-3920-41AB-A519-8CAE0E7962AAQ36853249-1984D161-DA2E-4205-9188-807279FAEA40
P2860
Antipsychotic-induced weight gain: a review of the literature.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antipsychotic-induced weight gain: a review of the literature.
@ast
Antipsychotic-induced weight gain: a review of the literature.
@en
Antipsychotic-induced weight gain: a review of the literature.
@nl
type
label
Antipsychotic-induced weight gain: a review of the literature.
@ast
Antipsychotic-induced weight gain: a review of the literature.
@en
Antipsychotic-induced weight gain: a review of the literature.
@nl
prefLabel
Antipsychotic-induced weight gain: a review of the literature.
@ast
Antipsychotic-induced weight gain: a review of the literature.
@en
Antipsychotic-induced weight gain: a review of the literature.
@nl
P1476
Antipsychotic-induced weight gain: a review of the literature.
@en
P2093
D B Allison
P478
62 Suppl 7
P577
2001-01-01T00:00:00Z